7/27/2020 PROFICIENCY TESTING SERVICE PAGE : 1 (27) … Documents/Participant... · 2020-07-27 ·...
27
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 225 HELICOBACTER PYLORI TEST SAMPLE LEVEL 1 RESULT CODE LEVEL 2 RESULT CODE LEVEL 3 RESULT CODE PART LOW/HIGH REFEREE LOW/HIGH COMMER LOW/HIGH REPORTED VALUE PART LABS # LABS ANSW # "SF" LABS Score 155 HELICOBACTER PYLORI 2020-381 017 INST.V.ALF 001 001 001 001 001 - NEGATIVE 24 23 23 100 2020-381 017 INST.V.ALF 001 001 001 001 002 - POSITIVE 24 1 23 0 2020-382 017 INST.V.ALF 001 001 001 001 002 - POSITIVE 24 1 23 0 2020-382 017 INST.V.ALF 001 001 001 001 001 - NEGATIVE 24 23 23 100 2020-383 017 INST.V.ALF 002 002 002 002 002 - POSITIVE 24 22 22 100 2020-383 017 INST.V.ALF 002 002 002 002 001 - NEGATIVE 24 2 22 0 2020-384 017 INST.V.ALF 002 002 002 002 001 - NEGATIVE 24 2 22 0 2020-384 017 INST.V.ALF 002 002 002 002 002 - POSITIVE 24 22 22 100 2020-385 017 INST.V.ALF 002 002 002 002 001 - NEGATIVE 24 1 23 0 2020-385 017 INST.V.ALF 002 002 002 002 002 - POSITIVE 24 23 23 100 SPEC: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP ANALYTE SAMPLE METHOD SYST/INST REAGENTS NO. PART LABS TARGET VALUE STANDARD DEVIATION % CV ACCEPTABLE LOW RANGE HIGH 145 CRP - QUANTITATIVE CLIA TEST ID #: 0 EVALUATION CRITERIA: TARGET VALUE 3 SD OR 10.00 {LOWER} 2020-351 1 BIOKIT RH. 21 2.800 1.003 35.82 0 5.810 2020-351 33 TECO DIAG. 10 3.360 3.465 103.13 0 13.360 7/27/2020 PROFICIENCY TESTING SERVICE LABORATORY SERVICES PROGRAM DEPARTMENT OF HEALTH OF PUERTO RICO MONTH 5 OF YEAR 2020 PAGE : 1 (27) DATE : 7/27/2020 TIME : 08:48:50 Participant Summary
Transcript of 7/27/2020 PROFICIENCY TESTING SERVICE PAGE : 1 (27) … Documents/Participant... · 2020-07-27 ·...
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 225 HELICOBACTER PYLORI
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
155 HELICOBACTER PYLORI
2020-381 017 INST.V.ALF 001 001 001 001 001 - NEGATIVE 24 23 23 100
2020-381 017 INST.V.ALF 001 001 001 001 002 - POSITIVE 24 1 23 0
2020-382 017 INST.V.ALF 001 001 001 001 002 - POSITIVE 24 1 23 0
2020-382 017 INST.V.ALF 001 001 001 001 001 - NEGATIVE 24 23 23 100
2020-383 017 INST.V.ALF 002 002 002 002 002 - POSITIVE 24 22 22 100
2020-383 017 INST.V.ALF 002 002 002 002 001 - NEGATIVE 24 2 22 0
2020-384 017 INST.V.ALF 002 002 002 002 001 - NEGATIVE 24 2 22 0
2020-384 017 INST.V.ALF 002 002 002 002 002 - POSITIVE 24 22 22 100
2020-385 017 INST.V.ALF 002 002 002 002 001 - NEGATIVE 24 1 23 0
2020-385 017 INST.V.ALF 002 002 002 002 002 - POSITIVE 24 23 23 100
SPEC: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
ANALYTE
SAMPLE METHOD SYST/INST REAGENTSNO. PARTLABS
TARGETVALUE
STANDARDDEVIATION
%CV
ACCEPTABLELOW
RANGEHIGH
145 CRP - QUANTITATIVE CLIA TEST ID #: 0 EVALUATION CRITERIA: TARGET VALUE 3 SD OR 10.00 {LOWER}
2020-351 1 BIOKIT RH. 21 2.800 1.003 35.82 0 5.810
2020-351 33 TECO DIAG. 10 3.360 3.465 103.13 0 13.360
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 1 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPEC: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
ANALYTE
SAMPLE METHOD SYST/INST REAGENTSNO. PARTLABS
TARGETVALUE
STANDARDDEVIATION
%CV
ACCEPTABLELOW
RANGEHIGH
2020-351 34 DADE DIMEN 18 2.872 0.132 4.59 2.480 3.270
2020-351 37 BECKMAN 12 2.578 0.184 7.15 2.020 3.130
2020-351 39 ROCHE COBA 13 2.510 0.192 7.66 1.930 3.090
2020-351 42 ASI ARLING 12 8.250 13.652 165.47 0 18.250
2020-351 47 VITROS 560 14 4.459 0.213 4.77 3.820 5.100
145 CRP - QUANTITATIVE CLIA TEST ID #: 0 EVALUATION CRITERIA: TARGET VALUE 3 SD OR 10.00 {LOWER}
2020-352 1 BIOKIT RH. 21 0.714 0.352 49.32 0 1.770
2020-352 33 TECO DIAG. 10 0.240 0.367 152.75 0 1.340
2020-352 34 DADE DIMEN 18 0.339 0.094 27.75 0.060 0.620
2020-352 37 BECKMAN 12 0.518 0.210 40.48 0 1.150
2020-352 39 ROCHE COBA 13 0.171 0.044 26.01 0.040 0.300
2020-352 42 ASI ARLING 12 0.109 0.231 212.13 0 0.800
2020-352 47 VITROS 560 14 0.500 0.000 0.00 0.500 0.500
2020-353 1 BIOKIT RH. 21 0.257 0.297 115.47 0 1.150
2020-353 33 TECO DIAG. 10 0.880 1.874 213.01 0 6.500
2020-353 34 DADE DIMEN 18 0.079 0.073 92.81 0 0.300
2020-353 37 BECKMAN 12 0.493 0.254 51.50 0 1.260
2020-353 39 ROCHE COBA 13 0.064 0.101 158.84 0 0.370
2020-353 42 ASI ARLING 12 0.109 0.231 212.13 0 0.800
2020-353 47 VITROS 560 14 0.500 0.000 0.00 0.500 0.500
2020-354 1 BIOKIT RH. 21 0.743 0.316 42.48 0 1.690
2020-354 33 TECO DIAG. 10 0.240 0.367 152.75 0 1.340
2020-354 34 DADE DIMEN 18 0.347 0.121 34.84 0 0.710
2020-354 37 BECKMAN 12 0.543 0.216 39.75 0 1.190
2020-354 39 ROCHE COBA 13 0.178 0.040 22.67 0.060 0.300
2020-354 42 ASI ARLING 12 0.109 0.231 212.13 0 0.800
2020-354 47 VITROS 560 14 0.500 0.000 0.00 0.500 0.500
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 2 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPEC: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
ANALYTE
SAMPLE METHOD SYST/INST REAGENTSNO. PARTLABS
TARGETVALUE
STANDARDDEVIATION
%CV
ACCEPTABLELOW
RANGEHIGH
145 CRP - QUANTITATIVE CLIA TEST ID #: 0 EVALUATION CRITERIA: TARGET VALUE 3 SD OR 10.00 {LOWER}
2020-355 1 BIOKIT RH. 21 0.257 0.297 115.47 0 1.150
2020-355 33 TECO DIAG. 10 0.240 0.367 152.75 0 1.340
2020-355 34 DADE DIMEN 18 0.088 0.073 82.39 0 0.310
2020-355 37 BECKMAN 12 0.510 0.257 50.44 0 1.280
2020-355 39 ROCHE COBA 13 0.064 0.101 158.84 0 0.370
2020-355 42 ASI ARLING 12 0.109 0.231 212.13 0 0.800
2020-355 47 VITROS 560 14 0.500 0.000 0.00 0.500 0.500
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
091 ANTISTREP.O-QUALITA.
2020-351 378 RHEUMAJET 001 001 001 001 001 - NEGATIVE 24 24 24 100
2020-351 384 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 23 23 23 100
2020-352 378 RHEUMAJET 001 001 001 001 001 - NEGATIVE 24 22 22 100
2020-352 378 RHEUMAJET 001 001 001 001 002 - POSITIVE 24 2 22 0
2020-352 384 ASI A.SCT. 001 001 002 - POSITIVE 23 5 18 0
2020-352 384 ASI A.SCT. 001 001 001 - NEGATIVE 23 18 18 100
2020-353 378 RHEUMAJET 002 002 002 002 002 - POSITIVE 24 24 24 100
2020-353 384 ASI A.SCT. 002 002 002 002 002 - POSITIVE 23 23 23 100
2020-354 378 RHEUMAJET 001 001 001 001 002 - POSITIVE 24 1 23 0
2020-354 378 RHEUMAJET 001 001 001 001 001 - NEGATIVE 24 23 23 100
2020-354 384 ASI A.SCT. 001 001 002 - POSITIVE 23 5 18 0
2020-354 384 ASI A.SCT. 001 001 001 - NEGATIVE 23 18 18 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 3 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
091 ANTISTREP.O-QUALITA.
2020-355 378 RHEUMAJET 001 001 001 001 001 - NEGATIVE 24 24 24 100
2020-355 384 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 23 22 22 100
2020-355 384 ASI A.SCT. 001 001 001 001 002 - POSITIVE 23 1 22 0
092 ANTISTREP.O-SEMI QUA
2020-351 381 RHEUMAJET 014 014 014 014 014 - <100 IU/ml 18 18 18 100
2020-352 381 RHEUMAJET 014 014 014 014 014 - <100 IU/ml 18 17 17 100
2020-352 381 RHEUMAJET 014 014 014 014 016 - 200 IU/ml 18 1 17 0
2020-353 381 RHEUMAJET 015 019 015 019 017 - 400 IU/ml 18 12 18 100
2020-353 381 RHEUMAJET 015 019 015 019 016 - 200 IU/ml 18 6 18 100
2020-354 381 RHEUMAJET 014 014 014 014 014 - <100 IU/ml 18 17 17 100
2020-354 381 RHEUMAJET 014 014 014 014 016 - 200 IU/ml 18 1 17 0
2020-355 381 RHEUMAJET 014 014 014 014 014 - <100 IU/ml 18 18 18 100
103 INF. MONO- QUALITAT.
2020-351 109 BIOKIT MON 001 001 001 001 001 - NEGATIVE 86 86 86 100
2020-351 383 IMMUNOLEX 001 001 001 001 001 - NEGATIVE 10 10 10 100
2020-351 389 MONOCOL/L. 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-351 393 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 125 125 125 100
2020-351 394 TECO DIAG 001 001 001 001 001 - NEGATIVE 53 53 53 100
2020-351 405 Acceava 001 001 001 001 001 - NEGATIVE 15 15 15 100
2020-352 109 BIOKIT MON 002 002 002 002 002 - POSITIVE 86 86 86 100
2020-352 383 IMMUNOLEX 002 002 002 002 002 - POSITIVE 10 10 10 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 4 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-352 389 MONOCOL/L. 002 002 002 002 002 - POSITIVE 12 12 12 100
2020-352 393 ASI A.SCT. 002 002 002 002 002 - POSITIVE 125 125 125 100
2020-352 394 TECO DIAG 002 002 002 002 002 - POSITIVE 53 53 53 100
2020-352 405 Acceava 002 002 002 002 002 - POSITIVE 15 15 15 100
103 INF. MONO- QUALITAT.
2020-353 109 BIOKIT MON 001 001 001 001 001 - NEGATIVE 86 86 86 100
2020-353 383 IMMUNOLEX 001 001 001 001 001 - NEGATIVE 10 10 10 100
2020-353 389 MONOCOL/L. 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-353 393 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 125 125 125 100
2020-353 394 TECO DIAG 001 001 001 001 001 - NEGATIVE 53 53 53 100
2020-353 405 Acceava 001 001 001 001 001 - NEGATIVE 15 15 15 100
2020-354 109 BIOKIT MON 002 002 002 002 002 - POSITIVE 86 84 84 100
2020-354 109 BIOKIT MON 002 002 002 002 001 - NEGATIVE 86 2 84 0
2020-354 383 IMMUNOLEX 002 002 002 002 002 - POSITIVE 10 10 10 100
2020-354 389 MONOCOL/L. 002 002 002 002 002 - POSITIVE 12 12 12 100
2020-354 393 ASI A.SCT. 002 002 002 002 002 - POSITIVE 125 125 125 100
2020-354 394 TECO DIAG 002 002 002 002 002 - POSITIVE 53 53 53 100
2020-354 405 Acceava 002 002 002 002 002 - POSITIVE 15 15 15 100
2020-355 109 BIOKIT MON 001 001 001 001 002 - POSITIVE 86 2 84 0
2020-355 109 BIOKIT MON 001 001 001 001 001 - NEGATIVE 86 84 84 100
2020-355 383 IMMUNOLEX 001 001 001 001 001 - NEGATIVE 10 10 10 100
2020-355 389 MONOCOL/L. 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-355 393 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 125 125 125 100
2020-355 394 TECO DIAG 001 001 001 001 001 - NEGATIVE 53 53 53 100
2020-355 405 Acceava 001 001 001 001 001 - NEGATIVE 15 15 15 100
105 RF FACTOR(RA)-QUALI.
2020-351 041 BIOKIT RHE 001 001 001 001 001 - NEGATIVE 23 23 23 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 5 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-351 393 RHEUMAJET 001 001 001 001 001 - NEGATIVE 89 89 89 100
2020-351 395 RHEUMACOL 001 001 001 001 001 - NEGATIVE 13 13 13 100
2020-351 400 TECO DIAG. 001 001 001 001 001 - NEGATIVE 59 59 59 100
2020-351 402 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 113 113 113 100
2020-351 406 AIM CRP RF 001 001 001 001 001 - NEGATIVE 26 26 26 100
2020-351 408 STANBIO 001 001 001 001 001 - NEGATIVE 27 27 27 100
2020-351 410 IMMUNOSTIC 001 001 001 001 001 - NEGATIVE 12 12 12 100
105 RF FACTOR(RA)-QUALI.
2020-352 041 BIOKIT RHE 002 002 002 002 002 - POSITIVE 23 23 23 100
2020-352 393 RHEUMAJET 002 002 002 002 002 - POSITIVE 89 89 89 100
2020-352 395 RHEUMACOL 002 002 002 002 002 - POSITIVE 13 13 13 100
2020-352 400 TECO DIAG. 002 002 002 002 002 - POSITIVE 59 59 59 100
2020-352 402 ASI A.SCT. 002 002 002 002 002 - POSITIVE 113 113 113 100
2020-352 406 AIM CRP RF 002 002 002 002 002 - POSITIVE 26 26 26 100
2020-352 408 STANBIO 002 002 002 002 002 - POSITIVE 27 27 27 100
2020-352 410 IMMUNOSTIC 002 002 002 002 002 - POSITIVE 12 12 12 100
2020-353 041 BIOKIT RHE 001 001 001 001 001 - NEGATIVE 23 23 23 100
2020-353 393 RHEUMAJET 001 001 001 001 001 - NEGATIVE 89 89 89 100
2020-353 395 RHEUMACOL 001 001 001 001 001 - NEGATIVE 13 13 13 100
2020-353 400 TECO DIAG. 001 001 001 001 001 - NEGATIVE 59 59 59 100
2020-353 402 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 113 113 113 100
2020-353 406 AIM CRP RF 001 001 001 001 001 - NEGATIVE 26 26 26 100
2020-353 408 STANBIO 001 001 001 001 001 - NEGATIVE 27 27 27 100
2020-353 410 IMMUNOSTIC 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-354 041 BIOKIT RHE 002 002 002 002 002 - POSITIVE 23 23 23 100
2020-354 393 RHEUMAJET 002 002 002 002 002 - POSITIVE 89 89 89 100
2020-354 395 RHEUMACOL 002 002 002 002 002 - POSITIVE 13 13 13 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 6 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-354 400 TECO DIAG. 002 002 002 002 002 - POSITIVE 59 59 59 100
2020-354 402 ASI A.SCT. 002 002 002 002 002 - POSITIVE 113 113 113 100
2020-354 406 AIM CRP RF 002 002 002 002 002 - POSITIVE 26 26 26 100
2020-354 408 STANBIO 002 002 002 002 002 - POSITIVE 27 27 27 100
2020-354 410 IMMUNOSTIC 002 002 002 002 002 - POSITIVE 12 12 12 100
105 RF FACTOR(RA)-QUALI.
2020-355 041 BIOKIT RHE 001 001 001 001 001 - NEGATIVE 23 23 23 100
2020-355 393 RHEUMAJET 001 001 001 001 001 - NEGATIVE 89 89 89 100
2020-355 395 RHEUMACOL 001 001 001 001 001 - NEGATIVE 13 13 13 100
2020-355 400 TECO DIAG. 001 001 001 001 001 - NEGATIVE 59 59 59 100
2020-355 402 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 113 113 113 100
2020-355 406 AIM CRP RF 001 001 001 001 001 - NEGATIVE 26 26 26 100
2020-355 408 STANBIO 001 001 001 001 001 - NEGATIVE 27 27 27 100
2020-355 410 IMMUNOSTIC 001 001 001 001 001 - NEGATIVE 12 12 12 100
106 RF FAC(RA)-SEMI QUAN
2020-351 393 RHEUMAJET 001 001 001 001 001 - <8-20 IU/m 44 44 44 100
2020-351 407 ASI SLIDE 001 001 001 001 001 - <8-20 IU/m 10 10 10 100
2020-352 393 RHEUMAJET 002 006 002 006 003 - 24-40 IU/m 44 8 44 100
2020-352 393 RHEUMAJET 002 006 002 006 005 - 72-160 IU 44 6 44 100
2020-352 393 RHEUMAJET 002 006 002 006 004 - 40-80 IU/m 44 30 44 100
2020-352 407 ASI SLIDE 005 009 002 006 007 - 264-640 IU 10 4 10 100
2020-352 407 ASI SLIDE 005 009 002 006 002 - 8-20 IU/ml 10 1 10 100
2020-352 407 ASI SLIDE 005 009 002 006 005 - 72-160 IU 10 3 10 100
2020-352 407 ASI SLIDE 005 009 002 006 006 - 136-320 IU 10 2 10 100
2020-353 393 RHEUMAJET 001 001 001 001 001 - <8-20 IU/m 44 44 44 100
2020-353 407 ASI SLIDE 001 001 001 001 001 - <8-20 IU/m 10 10 10 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 7 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
106 RF FAC(RA)-SEMI QUAN
2020-354 393 RHEUMAJET 002 006 002 006 005 - 72-160 IU 44 6 44 100
2020-354 393 RHEUMAJET 002 006 002 006 003 - 24-40 IU/m 44 3 44 100
2020-354 393 RHEUMAJET 002 006 002 006 004 - 40-80 IU/m 44 35 44 100
2020-354 407 ASI SLIDE 003 007 002 006 007 - 264-640 IU 10 2 9 100
2020-354 407 ASI SLIDE 003 007 002 006 002 - 8-20 IU/ml 10 1 9 100
2020-354 407 ASI SLIDE 003 007 002 006 008 - 520-1280 10 1 9 0
2020-354 407 ASI SLIDE 003 007 002 006 006 - 136-320 IU 10 3 9 100
2020-354 407 ASI SLIDE 003 007 002 006 005 - 72-160 IU 10 3 9 100
2020-355 393 RHEUMAJET 001 001 001 001 001 - <8-20 IU/m 44 44 44 100
2020-355 407 ASI SLIDE 001 001 001 001 001 - <8-20 IU/m 10 10 10 100
144 CRP- QUALITATIVE
2020-351 001 BIOKIT RH. 002 002 002 002 002 - POSITIVE 81 81 81 100
2020-351 010 IMMUNOSTIC 002 002 002 002 002 - POSITIVE 18 18 18 100
2020-351 021 RHEUMAGEN 002 002 002 002 002 - POSITIVE 16 16 16 100
2020-351 026 ASI A.SCT. 002 002 002 002 002 - POSITIVE 96 96 96 100
2020-351 030 TECO DIAG. 002 002 002 002 001 - NEGATIVE 53 1 52 0
2020-351 030 TECO DIAG. 002 002 002 002 002 - POSITIVE 53 52 52 100
2020-351 036 AIM CRP RF 002 002 002 002 002 - POSITIVE 31 31 31 100
2020-352 001 BIOKIT RH. 001 - NEGATIVE 81 18 81 0
2020-352 001 BIOKIT RH. 002 - POSITIVE 81 63 81 0
2020-352 010 IMMUNOSTIC 001 001 002 - POSITIVE 18 3 15 0
2020-352 010 IMMUNOSTIC 001 001 001 - NEGATIVE 18 15 15 100
2020-352 021 RHEUMAGEN 002 - POSITIVE 16 10 16 0
2020-352 021 RHEUMAGEN 001 - NEGATIVE 16 6 16 0
2020-352 026 ASI A.SCT. 001 001 002 - POSITIVE 96 1 95 0
2020-352 026 ASI A.SCT. 001 001 001 - NEGATIVE 96 95 95 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 8 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-352 030 TECO DIAG. 001 001 002 - POSITIVE 53 1 52 0
2020-352 030 TECO DIAG. 001 001 001 - NEGATIVE 53 52 52 100
2020-352 036 AIM CRP RF 001 001 001 - NEGATIVE 31 31 31 100
144 CRP- QUALITATIVE
2020-353 001 BIOKIT RH. 001 001 001 001 001 - NEGATIVE 81 81 81 100
2020-353 010 IMMUNOSTIC 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-353 021 RHEUMAGEN 001 001 001 001 001 - NEGATIVE 16 16 16 100
2020-353 026 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 96 96 96 100
2020-353 030 TECO DIAG. 001 001 001 001 002 - POSITIVE 53 1 52 0
2020-353 030 TECO DIAG. 001 001 001 001 001 - NEGATIVE 53 52 52 100
2020-353 036 AIM CRP RF 001 001 001 001 001 - NEGATIVE 31 31 31 100
2020-354 001 BIOKIT RH. 001 - NEGATIVE 81 20 81 0
2020-354 001 BIOKIT RH. 002 - POSITIVE 81 61 81 0
2020-354 010 IMMUNOSTIC 002 - POSITIVE 18 4 18 0
2020-354 010 IMMUNOSTIC 001 - NEGATIVE 18 14 18 0
2020-354 021 RHEUMAGEN 001 - NEGATIVE 16 4 16 0
2020-354 021 RHEUMAGEN 002 - POSITIVE 16 12 16 0
2020-354 026 ASI A.SCT. 001 001 002 - POSITIVE 96 2 94 0
2020-354 026 ASI A.SCT. 001 001 001 - NEGATIVE 96 94 94 100
2020-354 030 TECO DIAG. 001 001 002 - POSITIVE 53 1 52 0
2020-354 030 TECO DIAG. 001 001 001 - NEGATIVE 53 52 52 100
2020-354 036 AIM CRP RF 001 001 001 - NEGATIVE 31 30 30 100
2020-354 036 AIM CRP RF 001 001 002 - POSITIVE 31 1 30 0
2020-355 001 BIOKIT RH. 001 001 001 001 001 - NEGATIVE 81 81 81 100
2020-355 010 IMMUNOSTIC 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-355 021 RHEUMAGEN 001 001 001 001 001 - NEGATIVE 16 16 16 100
2020-355 026 ASI A.SCT. 001 001 001 001 001 - NEGATIVE 96 95 95 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 9 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 220 ASOT, RA, MONO, CRP
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-355 026 ASI A.SCT. 001 001 001 001 002 - POSITIVE 96 1 95 0
2020-355 030 TECO DIAG. 001 001 001 001 001 - NEGATIVE 53 52 52 100
2020-355 030 TECO DIAG. 001 001 001 001 002 - POSITIVE 53 1 52 0
2020-355 036 AIM CRP RF 001 001 001 001 001 - NEGATIVE 31 31 31 100
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 240 RUBELLA - QUALITAT.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
107 RUBELLA-QUALITATIVE
2020-331 164 RUBAGEN B. 001 001 001 001 002 - POS.OR IM. 11 1 10 0
2020-331 164 RUBAGEN B. 001 001 001 001 001 - NEG-NOT IM 11 10 10 100
2020-332 164 RUBAGEN B. 002 002 002 002 002 - POS.OR IM. 11 11 11 100
2020-333 164 RUBAGEN B. 001 001 001 001 001 - NEG-NOT IM 11 11 11 100
2020-334 164 RUBAGEN B. 002 002 002 002 002 - POS.OR IM. 11 11 11 100
2020-335 164 RUBAGEN B. 001 001 001 001 001 - NEG-NOT IM 11 11 11 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 10 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 120 GENERAL GRP: 247 MYCOPLASMA
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
548 MYCOPLASMA
2020-121 001 IMMU. CARD 002 002 002 - Reactive 234 233 233 100
2020-121 001 IMMU. CARD 002 002 001 - Non Reacti 234 1 233 0
2020-122 001 IMMU. CARD 001 001 001 - Non Reacti 234 234 234 100
2020-123 001 IMMU. CARD 002 002 002 - Reactive 234 234 234 100
2020-124 001 IMMU. CARD 001 001 001 - Non Reacti 234 234 234 100
2020-125 001 IMMU. CARD 002 002 002 - Reactive 234 234 234 100
SPE: 40 IMMUNOLOGY SUB: 130 SYPHILIS SEROLOGY GRP: 250 SYPHILIS SEROLOGY
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
109 SYPHILLIS SERO.-QUAL
2020-321 002 RPR 028 BIOKIT-RPR 001 001 001 001 001 - NR Non Rea 74 74 74 100
2020-321 002 RPR 030 IMMUNOSTIC 001 001 001 001 001 - NR Non Rea 164 164 164 100
2020-321 002 RPR 033 ASI 001 001 001 001 001 - NR Non Rea 358 358 358 100
2020-321 002 RPR 040 TECO DIAG. 001 001 001 001 001 - NR Non Rea 73 73 73 100
2020-321 002 RPR 053 AIM RPR 001 001 001 001 001 - NR Non Rea 47 47 47 100
2020-321 002 RPR 057 Germain La 001 001 001 001 001 - NR Non Rea 15 15 15 100
2020-322 002 RPR 028 BIOKIT-RPR 004 004 004 004 004 - React RPR 74 74 74 100
2020-322 002 RPR 030 IMMUNOSTIC 004 004 004 004 004 - React RPR 164 164 164 100
2020-322 002 RPR 033 ASI 004 004 004 004 004 - React RPR 358 358 358 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 11 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 130 SYPHILIS SEROLOGY GRP: 250 SYPHILIS SEROLOGY
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-322 002 RPR 040 TECO DIAG. 004 004 004 004 004 - React RPR 73 73 73 100
2020-322 002 RPR 053 AIM RPR 004 004 004 004 004 - React RPR 47 47 47 100
2020-322 002 RPR 057 Germain La 004 004 004 004 004 - React RPR 15 15 15 100
109 SYPHILLIS SERO.-QUAL
2020-323 002 RPR 028 BIOKIT-RPR 004 004 004 004 004 - React RPR 74 74 74 100
2020-323 002 RPR 030 IMMUNOSTIC 004 004 004 004 004 - React RPR 164 164 164 100
2020-323 002 RPR 033 ASI 004 004 004 004 004 - React RPR 358 357 357 100
2020-323 002 RPR 033 ASI 004 004 004 004 002 - WR Weakly 358 1 357 0
2020-323 002 RPR 040 TECO DIAG. 004 004 004 004 004 - React RPR 73 73 73 100
2020-323 002 RPR 053 AIM RPR 004 004 004 004 004 - React RPR 47 47 47 100
2020-323 002 RPR 057 Germain La 004 004 004 004 004 - React RPR 15 14 14 100
2020-323 002 RPR 057 Germain La 004 004 004 004 001 - NR Non Rea 15 1 14 0
2020-324 002 RPR 028 BIOKIT-RPR 001 001 001 001 001 - NR Non Rea 74 74 74 100
2020-324 002 RPR 030 IMMUNOSTIC 001 001 001 001 001 - NR Non Rea 164 164 164 100
2020-324 002 RPR 033 ASI 001 001 001 001 001 - NR Non Rea 358 358 358 100
2020-324 002 RPR 040 TECO DIAG. 001 001 001 001 004 - React RPR 73 1 72 0
2020-324 002 RPR 040 TECO DIAG. 001 001 001 001 001 - NR Non Rea 73 72 72 100
2020-324 002 RPR 053 AIM RPR 001 001 001 001 001 - NR Non Rea 47 47 47 100
2020-324 002 RPR 057 Germain La 001 001 001 001 004 - React RPR 15 1 14 0
2020-324 002 RPR 057 Germain La 001 001 001 001 001 - NR Non Rea 15 14 14 100
2020-325 002 RPR 028 BIOKIT-RPR 004 004 004 004 004 - React RPR 74 74 74 100
2020-325 002 RPR 030 IMMUNOSTIC 004 004 004 004 004 - React RPR 164 164 164 100
2020-325 002 RPR 033 ASI 004 004 004 004 004 - React RPR 358 358 358 100
2020-325 002 RPR 040 TECO DIAG. 004 004 004 004 004 - React RPR 73 73 73 100
2020-325 002 RPR 053 AIM RPR 004 004 004 004 004 - React RPR 47 47 47 100
2020-325 002 RPR 057 Germain La 004 004 004 004 004 - React RPR 15 15 15 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 12 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 130 SYPHILIS SEROLOGY GRP: 250 SYPHILIS SEROLOGY
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
110 SYPHILLIS SERO-QUANT
2020-321 002 RPR 028 BIOKIT-RPR 001 001 001 001 001 - NR 59 59 59 100
2020-321 002 RPR 030 IMMUNOSTIC 001 001 001 001 001 - NR 69 69 69 100
2020-321 002 RPR 033 ASI 001 001 001 001 001 - NR 154 154 154 100
2020-321 002 RPR 040 TECO DIAG. 001 001 001 001 001 - NR 20 20 20 100
2020-322 002 RPR 028 BIOKIT-RPR 004 006 004 006 007 - R- 16 DILS 59 1 58 0
2020-322 002 RPR 028 BIOKIT-RPR 004 006 004 006 005 - R- 4 DILS. 59 39 58 100
2020-322 002 RPR 028 BIOKIT-RPR 004 006 004 006 006 - R- 8 DILS. 59 18 58 100
2020-322 002 RPR 028 BIOKIT-RPR 004 006 004 006 004 - R- 2 DILS. 59 1 58 100
2020-322 002 RPR 030 IMMUNOSTIC 004 006 004 006 005 - R- 4 DILS. 69 39 69 100
2020-322 002 RPR 030 IMMUNOSTIC 004 006 004 006 006 - R- 8 DILS. 69 28 69 100
2020-322 002 RPR 030 IMMUNOSTIC 004 006 004 006 004 - R- 2 DILS. 69 2 69 100
2020-322 002 RPR 033 ASI 004 006 004 006 004 - R- 2 DILS. 154 7 154 100
2020-322 002 RPR 033 ASI 004 006 004 006 006 - R- 8 DILS. 154 50 154 100
2020-322 002 RPR 033 ASI 004 006 004 006 005 - R- 4 DILS. 154 97 154 100
2020-322 002 RPR 040 TECO DIAG. 004 006 004 006 006 - R- 8 DILS. 20 1 20 100
2020-322 002 RPR 040 TECO DIAG. 004 006 004 006 005 - R- 4 DILS. 20 17 20 100
2020-322 002 RPR 040 TECO DIAG. 004 006 004 006 004 - R- 2 DILS. 20 2 20 100
2020-323 002 RPR 028 BIOKIT-RPR 003 005 003 005 004 - R- 2 DILS. 59 33 57 100
2020-323 002 RPR 028 BIOKIT-RPR 003 005 003 005 006 - R- 8 DILS. 59 2 57 0
2020-323 002 RPR 028 BIOKIT-RPR 003 005 003 005 005 - R- 4 DILS. 59 24 57 100
2020-323 002 RPR 030 IMMUNOSTIC 004 006 003 005 006 - R- 8 DILS. 69 3 69 100
2020-323 002 RPR 030 IMMUNOSTIC 004 006 003 005 005 - R- 4 DILS. 69 33 69 100
2020-323 002 RPR 030 IMMUNOSTIC 004 006 003 005 004 - R- 2 DILS. 69 33 69 100
2020-323 002 RPR 033 ASI 003 005 003 005 002 - WR- 0 DIL. 154 2 151 0
2020-323 002 RPR 033 ASI 003 005 003 005 004 - R- 2 DILS. 154 94 151 100
2020-323 002 RPR 033 ASI 003 005 003 005 003 - R- 1 DIL. 154 1 151 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 13 (27)DATE : 7/27/2020TIME : 08:48:50
Participant Summary
SPE: 40 IMMUNOLOGY SUB: 130 SYPHILIS SEROLOGY GRP: 250 SYPHILIS SEROLOGY
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-323 002 RPR 033 ASI 003 005 003 005 005 - R- 4 DILS. 154 56 151 100
2020-323 002 RPR 033 ASI 003 005 003 005 006 - R- 8 DILS. 154 1 151 0
2020-323 002 RPR 040 TECO DIAG. 003 005 003 005 005 - R- 4 DILS. 20 3 20 100
2020-323 002 RPR 040 TECO DIAG. 003 005 003 005 004 - R- 2 DILS. 20 15 20 100
2020-323 002 RPR 040 TECO DIAG. 003 005 003 005 003 - R- 1 DIL. 20 2 20 100
110 SYPHILLIS SERO-QUANT
2020-324 002 RPR 028 BIOKIT-RPR 001 001 001 001 001 - NR 59 59 59 100
2020-324 002 RPR 030 IMMUNOSTIC 001 001 001 001 001 - NR 69 69 69 100
2020-324 002 RPR 033 ASI 001 001 001 001 001 - NR 154 154 154 100
2020-324 002 RPR 040 TECO DIAG. 001 001 001 001 001 - NR 20 20 20 100
2020-325 002 RPR 028 BIOKIT-RPR 003 005 003 005 005 - R- 4 DILS. 59 18 58 100
2020-325 002 RPR 028 BIOKIT-RPR 003 005 003 005 006 - R- 8 DILS. 59 1 58 0
2020-325 002 RPR 028 BIOKIT-RPR 003 005 003 005 004 - R- 2 DILS. 59 40 58 100
2020-325 002 RPR 030 IMMUNOSTIC 003 005 003 005 004 - R- 2 DILS. 69 38 67 100
2020-325 002 RPR 030 IMMUNOSTIC 003 005 003 005 005 - R- 4 DILS. 69 29 67 100
2020-325 002 RPR 030 IMMUNOSTIC 003 005 003 005 006 - R- 8 DILS. 69 2 67 0
2020-325 002 RPR 033 ASI 003 005 003 005 006 - R- 8 DILS. 154 2 152 0
2020-325 002 RPR 033 ASI 003 005 003 005 003 - R- 1 DIL. 154 2 152 100
2020-325 002 RPR 033 ASI 003 005 003 005 004 - R- 2 DILS. 154 86 152 100
2020-325 002 RPR 033 ASI 003 005 003 005 005 - R- 4 DILS. 154 64 152 100
2020-325 002 RPR 040 TECO DIAG. 003 005 003 005 005 - R- 4 DILS. 20 2 20 100
2020-325 002 RPR 040 TECO DIAG. 003 005 003 005 004 - R- 2 DILS. 20 18 20 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 14 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 260 BACTER. -GRAM STAIN
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
111 BACTER. GRAM STAIN
2020-221 001 001 001 001 001 - GRAM NEG. 67 67 67 100
2020-222 002 002 002 002 002 - GRAM POS. 67 67 67 100
2020-223 002 002 002 002 002 - GRAM POS. 67 67 67 100
2020-224 001 001 001 001 001 - GRAM NEG. 67 67 67 100
2020-225 001 001 001 001 002 - GRAM POS. 67 1 66 0
2020-225 001 001 001 001 001 - GRAM NEG. 67 66 66 100
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 270 BACTERIOLOGY IDENT.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
112 BACTER.-IDENTIFICAT.
2020-241 001 AEROBIC 001 CONVENCIO. 209 209 209 - Strep. pn. 12 9 12 100
2020-241 001 AEROBIC 001 CONVENCIO. 207 207 191 - Strep. sp. 12 3 12 100
2020-241 001 AEROBIC 032 MICROSCAN 207 207 207 - Strep. mi. 30 7 29 100
2020-241 001 AEROBIC 032 MICROSCAN 209 209 209 - Strep. pn. 30 22 29 100
2020-241 001 AEROBIC 032 MICROSCAN 207 207 193 - Strep ap v 30 1 29 0
2020-241 001 AEROBIC 034 MICROSCAN 207 207 204 - Strep. an. 27 1 25 0
2020-241 001 AEROBIC 034 MICROSCAN 209 209 209 - Strep. pn. 27 16 25 100
2020-241 001 AEROBIC 034 MICROSCAN 207 207 193 - Strep ap v 27 1 25 0
2020-241 001 AEROBIC 034 MICROSCAN 207 207 207 - Strep. mi. 27 8 25 100
2020-241 001 AEROBIC 034 MICROSCAN 209 209 191 - Strep. sp. 27 1 25 100
2020-241 001 AEROBIC 046 MICROSCAN 207 207 193 - Strep ap v 52 4 46 0
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 15 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 270 BACTERIOLOGY IDENT.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-241 001 AEROBIC 046 MICROSCAN 209 209 209 - Strep. pn. 52 31 46 100
2020-241 001 AEROBIC 046 MICROSCAN 207 207 205 - Strep. bo. 52 1 46 0
2020-241 001 AEROBIC 046 MICROSCAN 209 209 256 - No Org. IS 52 1 46 0
2020-241 001 AEROBIC 046 MICROSCAN 207 207 191 - Strep. sp. 52 4 46 100
2020-241 001 AEROBIC 046 MICROSCAN 207 207 207 - Strep. mi. 52 11 46 100
2020-241 001 AEROBIC 049 VITEK 2 207 207 193 - Strep ap v 57 2 55 0
2020-241 001 AEROBIC 049 VITEK 2 209 209 209 - Strep. pn. 57 38 55 100
2020-241 001 AEROBIC 049 VITEK 2 207 207 207 - Strep. mi. 57 17 55 100
112 BACTER.-IDENTIFICAT.
2020-242 001 AEROBIC 001 CONVENCIO. 188 188 188 - Staphy. ep 14 4 12 100
2020-242 001 AEROBIC 001 CONVENCIO. 195 195 195 - Strp bet A 14 8 12 100
2020-242 001 AEROBIC 001 CONVENCIO. 207 207 193 - Strep ap v 14 2 12 0
2020-242 001 AEROBIC 032 MICROSCAN 188 188 188 - Staphy. ep 68 22 64 100
2020-242 001 AEROBIC 032 MICROSCAN 195 195 195 - Strp bet A 68 26 64 100
2020-242 001 AEROBIC 032 MICROSCAN 207 207 185 - Staphy. co 68 1 64 0
2020-242 001 AEROBIC 032 MICROSCAN 207 207 187 - Staphy. au 68 2 64 0
2020-242 001 AEROBIC 032 MICROSCAN 207 207 193 - Strep ap v 68 1 64 0
2020-242 001 AEROBIC 032 MICROSCAN 207 207 207 - Strep. mi. 68 16 64 100
2020-242 001 AEROBIC 034 MICROSCAN 207 207 193 - Strep ap v 66 2 62 0
2020-242 001 AEROBIC 034 MICROSCAN 207 207 207 - Strep. mi. 66 17 62 100
2020-242 001 AEROBIC 034 MICROSCAN 207 207 205 - Strep. bo. 66 2 62 0
2020-242 001 AEROBIC 034 MICROSCAN 188 188 188 - Staphy. ep 66 23 62 100
2020-242 001 AEROBIC 034 MICROSCAN 195 195 195 - Strp bet A 66 22 62 100
2020-242 001 AEROBIC 042 VITEK(AMS) 195 195 195 - Strp bet A 19 5 17 100
2020-242 001 AEROBIC 042 VITEK(AMS) 207 207 198 - Strep. aga 19 1 17 0
2020-242 001 AEROBIC 042 VITEK(AMS) 207 207 193 - Strep ap v 19 1 17 0
2020-242 001 AEROBIC 042 VITEK(AMS) 207 207 191 - Strep. sp. 19 1 17 100
2020-242 001 AEROBIC 042 VITEK(AMS) 207 207 207 - Strep. mi. 19 4 17 100
2020-242 001 AEROBIC 042 VITEK(AMS) 188 188 188 - Staphy. ep 19 7 17 100
2020-242 001 AEROBIC 046 MICROSCAN 207 207 207 - Strep. mi. 87 11 82 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 16 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 270 BACTERIOLOGY IDENT.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-242 001 AEROBIC 046 MICROSCAN 188 188 184 - Staphy. sp 87 1 82 100
2020-242 001 AEROBIC 046 MICROSCAN 207 207 193 - Strep ap v 87 3 82 0
2020-242 001 AEROBIC 046 MICROSCAN 188 188 188 - Staphy. ep 87 37 82 100
2020-242 001 AEROBIC 046 MICROSCAN 195 195 195 - Strp bet A 87 33 82 100
2020-242 001 AEROBIC 046 MICROSCAN 207 207 187 - Staphy. au 87 2 82 0
2020-242 001 AEROBIC 049 VITEK 2 207 207 193 - Strep ap v 115 3 110 0
2020-242 001 AEROBIC 049 VITEK 2 207 207 211 - Strp sa 1 115 1 110 0
2020-242 001 AEROBIC 049 VITEK 2 195 195 195 - Strp bet A 115 40 110 100
2020-242 001 AEROBIC 049 VITEK 2 188 188 188 - Staphy. ep 115 39 110 100
2020-242 001 AEROBIC 049 VITEK 2 207 207 207 - Strep. mi. 115 28 110 100
2020-242 001 AEROBIC 049 VITEK 2 207 207 189 - Staphy. he 115 1 110 0
2020-242 001 AEROBIC 049 VITEK 2 207 207 191 - Strep. sp. 115 3 110 100
112 BACTER.-IDENTIFICAT.
2020-243 001 AEROBIC 001 CONVENCIO. 251 251 251 - NO S.Sh.Y. 19 19 19 100
2020-243 001 AEROBIC 032 MICROSCAN 251 251 068 - Escher. co 21 1 20 0
2020-243 001 AEROBIC 032 MICROSCAN 251 251 251 - NO S.Sh.Y. 21 20 20 100
2020-243 001 AEROBIC 034 MICROSCAN 251 251 256 - No Org. IS 23 1 22 0
2020-243 001 AEROBIC 034 MICROSCAN 251 251 251 - NO S.Sh.Y. 23 22 22 100
2020-243 001 AEROBIC 046 MICROSCAN 251 251 068 - Escher. co 36 2 33 0
2020-243 001 AEROBIC 046 MICROSCAN 251 251 251 - NO S.Sh.Y. 36 33 33 100
2020-243 001 AEROBIC 046 MICROSCAN 251 251 198 - Strep. aga 36 1 33 0
2020-243 001 AEROBIC 049 VITEK 2 251 251 251 - NO S.Sh.Y. 37 36 36 100
2020-243 001 AEROBIC 049 VITEK 2 251 251 256 - No Org. IS 37 1 36 0
2020-244 001 AEROBIC 032 MICROSCAN 070 070 070 - Entero. ae 27 27 27 100
2020-244 001 AEROBIC 034 MICROSCAN 070 070 070 - Entero. ae 26 26 26 100
2020-244 001 AEROBIC 046 MICROSCAN 070 070 070 - Entero. ae 41 41 41 100
2020-244 001 AEROBIC 049 VITEK 2 070 070 070 - Entero. ae 41 41 41 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 17 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 270 BACTERIOLOGY IDENT.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
112 BACTER.-IDENTIFICAT.
2020-245 001 AEROBIC 032 MICROSCAN 137 137 137 - Proteu. mi 27 27 27 100
2020-245 001 AEROBIC 034 MICROSCAN 137 137 137 - Proteu. mi 26 26 26 100
2020-245 001 AEROBIC 046 MICROSCAN 137 137 137 - Proteu. mi 41 40 40 100
2020-245 001 AEROBIC 046 MICROSCAN 137 137 146 - Pseudo. ae 41 1 40 0
2020-245 001 AEROBIC 049 VITEK 2 137 137 137 - Proteu. mi 40 40 40 100
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 280 BACT. ANTIMIC. SUSC.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
113 BACT.ANTIM. SUSCEPT.
2020-244 004 MICRO SCAN 001 AMIKACIN 000 Not apply 001 001 001 - SUSCEPTIB. 60 60 60 100
2020-244 004 MICRO SCAN 003 AMPICILLIN 000 Not apply 004 004 001 - SUSCEPTIB. 30 3 27 0
2020-244 004 MICRO SCAN 003 AMPICILLIN 000 Not apply 004 004 004 - RESISTANT 30 27 27 100
2020-244 004 MICRO SCAN 007 AZTREONAM 000 Not apply 001 001 001 - SUSCEPTIB. 17 17 17 100
2020-244 004 MICRO SCAN 020 CEFTAZIDIM 000 Not apply 001 001 001 - SUSCEPTIB. 18 18 18 100
2020-244 004 MICRO SCAN 029 CIPROFLOXA 000 Not apply 001 001 001 - SUSCEPTIB. 75 74 74 100
2020-244 004 MICRO SCAN 029 CIPROFLOXA 000 Not apply 001 001 004 - RESISTANT 75 1 74 0
2020-244 004 MICRO SCAN 037 GENTAMICIN 000 Not apply 001 001 001 - SUSCEPTIB. 57 57 57 100
2020-244 004 MICRO SCAN 050 NITROFURAN 000 Not apply 004 004 004 - RESISTANT 22 19 19 100
2020-244 004 MICRO SCAN 050 NITROFURAN 000 Not apply 004 004 001 - SUSCEPTIB. 22 3 19 0
2020-244 004 MICRO SCAN 062 TETRACYCLI 000 Not apply 001 001 001 - SUSCEPTIB. 15 15 15 100
2020-244 004 MICRO SCAN 065 TOBRAMYCIN 000 Not apply 001 001 001 - SUSCEPTIB. 67 67 67 100
2020-244 004 MICRO SCAN 066 TRIMETHOPR 000 Not apply 001 001 001 - SUSCEPTIB. 22 22 22 100
2020-244 004 MICRO SCAN 067 TRIME/SULF 000 Not apply 001 001 001 - SUSCEPTIB. 75 75 75 100
2020-244 004 MICRO SCAN 072 CEFEPIME 000 Not apply 001 001 001 - SUSCEPTIB. 35 35 35 100
2020-244 004 MICRO SCAN 073 PIPER/TAZO 000 Not apply 001 001 001 - SUSCEPTIB. 22 22 22 100
2020-244 004 MICRO SCAN 080 LEVOFLOXA. 000 Not apply 001 001 001 - SUSCEPTIB. 51 51 51 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 18 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 280 BACT. ANTIMIC. SUSC.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-244 004 MICRO SCAN 087 MEROPENEM 000 Not apply 001 001 001 - SUSCEPTIB. 10 10 10 100
2020-244 004 MICRO SCAN 096 ERTAPENEM 000 Not apply 001 001 001 - SUSCEPTIB. 20 20 20 100
2020-244 006 VITEK SYS. 001 AMIKACIN 000 Not apply 001 001 001 - SUSCEPTIB. 17 17 17 100
2020-244 006 VITEK SYS. 010 CEFAZOLIN 000 Not apply 004 004 001 - SUSCEPTIB. 17 1 16 0
2020-244 006 VITEK SYS. 010 CEFAZOLIN 000 Not apply 004 004 004 - RESISTANT 17 16 16 100
2020-244 006 VITEK SYS. 020 CEFTAZIDIM 000 Not apply 001 001 001 - SUSCEPTIB. 18 18 18 100
2020-244 006 VITEK SYS. 022 CEFTRIAXON 000 Not apply 001 001 001 - SUSCEPTIB. 16 16 16 100
2020-244 006 VITEK SYS. 029 CIPROFLOXA 000 Not apply 001 001 001 - SUSCEPTIB. 43 43 43 100
2020-244 006 VITEK SYS. 037 GENTAMICIN 000 Not apply 001 001 001 - SUSCEPTIB. 32 32 32 100
2020-244 006 VITEK SYS. 050 NITROFURAN 000 Not apply 004 004 001 - SUSCEPTIB. 19 1 16 0
2020-244 006 VITEK SYS. 050 NITROFURAN 000 Not apply 004 004 002 - INTERMEDI. 19 2 16 0
2020-244 006 VITEK SYS. 050 NITROFURAN 000 Not apply 004 004 004 - RESISTANT 19 16 16 100
2020-244 006 VITEK SYS. 065 TOBRAMYCIN 000 Not apply 001 001 001 - SUSCEPTIB. 25 25 25 100
2020-244 006 VITEK SYS. 067 TRIME/SULF 000 Not apply 001 001 001 - SUSCEPTIB. 43 43 43 100
2020-244 006 VITEK SYS. 072 CEFEPIME 000 Not apply 001 001 001 - SUSCEPTIB. 36 36 36 100
2020-244 006 VITEK SYS. 073 PIPER/TAZO 000 Not apply 001 001 001 - SUSCEPTIB. 26 26 26 100
2020-244 006 VITEK SYS. 080 LEVOFLOXA. 000 Not apply 001 001 001 - SUSCEPTIB. 15 15 15 100
2020-244 006 VITEK SYS. 096 ERTAPENEM 000 Not apply 001 001 001 - SUSCEPTIB. 25 25 25 100
113 BACT.ANTIM. SUSCEPT.
2020-245 004 MICRO SCAN 001 AMIKACIN 000 Not apply 001 001 001 - SUSCEPTIB. 56 56 56 100
2020-245 004 MICRO SCAN 002 AMOX/CLAVU 000 Not apply 001 001 001 - SUSCEPTIB. 18 18 18 100
2020-245 004 MICRO SCAN 003 AMPICILLIN 000 Not apply 001 001 001 - SUSCEPTIB. 58 58 57 100
2020-245 004 MICRO SCAN 003 AMPICILLIN 000 Not apply 001 001 001 - SUSCEPTIB. 58 58 57 0
2020-245 004 MICRO SCAN 004 AMPIC/SULB 000 Not apply 001 001 001 - SUSCEPTIB. 20 20 20 100
2020-245 004 MICRO SCAN 007 AZTREONAM 000 Not apply 001 001 001 - SUSCEPTIB. 17 17 17 100
2020-245 004 MICRO SCAN 010 CEFAZOLIN 000 Not apply 001 001 001 - SUSCEPTIB. 38 38 38 100
2020-245 004 MICRO SCAN 020 CEFTAZIDIM 000 Not apply 001 001 001 - SUSCEPTIB. 19 19 19 100
2020-245 004 MICRO SCAN 029 CIPROFLOXA 000 Not apply 001 001 001 - SUSCEPTIB. 74 74 73 100
2020-245 004 MICRO SCAN 029 CIPROFLOXA 000 Not apply 001 001 001 - SUSCEPTIB. 74 74 73 0
2020-245 004 MICRO SCAN 037 GENTAMICIN 000 Not apply 001 001 001 - SUSCEPTIB. 55 55 55 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 19 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 140 BACTERIOLOGY GRP: 280 BACT. ANTIMIC. SUSC.
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-245 004 MICRO SCAN 050 NITROFURAN 000 Not apply 004 004 001 - SUSCEPTIB. 30 1 28 0
2020-245 004 MICRO SCAN 050 NITROFURAN 000 Not apply 004 004 004 - RESISTANT 30 29 28 100
2020-245 004 MICRO SCAN 050 NITROFURAN 000 Not apply 004 004 004 - RESISTANT 30 29 28 0
2020-245 004 MICRO SCAN 065 TOBRAMYCIN 000 Not apply 001 001 001 - SUSCEPTIB. 65 65 65 100
2020-245 004 MICRO SCAN 066 TRIMETHOPR 000 Not apply 001 001 001 - SUSCEPTIB. 16 16 16 100
2020-245 004 MICRO SCAN 067 TRIME/SULF 000 Not apply 001 001 001 - SUSCEPTIB. 71 71 71 100
2020-245 004 MICRO SCAN 072 CEFEPIME 000 Not apply 001 001 001 - SUSCEPTIB. 35 35 35 100
2020-245 004 MICRO SCAN 073 PIPER/TAZO 000 Not apply 001 001 001 - SUSCEPTIB. 21 21 21 100
2020-245 004 MICRO SCAN 080 LEVOFLOXA. 000 Not apply 001 001 001 - SUSCEPTIB. 49 49 48 100
2020-245 004 MICRO SCAN 080 LEVOFLOXA. 000 Not apply 001 001 001 - SUSCEPTIB. 49 49 48 0
2020-245 004 MICRO SCAN 087 MEROPENEM 000 Not apply 001 001 001 - SUSCEPTIB. 10 10 10 100
2020-245 004 MICRO SCAN 096 ERTAPENEM 000 Not apply 001 001 001 - SUSCEPTIB. 14 14 14 100
2020-245 006 VITEK SYS. 001 AMIKACIN 000 Not apply 001 001 001 - SUSCEPTIB. 16 16 16 100
2020-245 006 VITEK SYS. 002 AMOX/CLAVU 000 Not apply 001 001 001 - SUSCEPTIB. 12 12 12 100
2020-245 006 VITEK SYS. 003 AMPICILLIN 000 Not apply 001 001 001 - SUSCEPTIB. 29 29 29 100
2020-245 006 VITEK SYS. 004 AMPIC/SULB 000 Not apply 001 001 001 - SUSCEPTIB. 14 14 14 100
2020-245 006 VITEK SYS. 010 CEFAZOLIN 000 Not apply 001 001 001 - SUSCEPTIB. 18 18 18 100
2020-245 006 VITEK SYS. 020 CEFTAZIDIM 000 Not apply 001 001 001 - SUSCEPTIB. 16 16 16 100
2020-245 006 VITEK SYS. 022 CEFTRIAXON 000 Not apply 001 001 001 - SUSCEPTIB. 15 15 15 100
2020-245 006 VITEK SYS. 029 CIPROFLOXA 000 Not apply 001 001 001 - SUSCEPTIB. 36 36 36 100
2020-245 006 VITEK SYS. 037 GENTAMICIN 000 Not apply 001 001 001 - SUSCEPTIB. 30 30 30 100
2020-245 006 VITEK SYS. 050 NITROFURAN 000 Not apply 004 004 004 - RESISTANT 27 26 26 100
2020-245 006 VITEK SYS. 050 NITROFURAN 000 Not apply 004 004 001 - SUSCEPTIB. 27 1 26 0
2020-245 006 VITEK SYS. 065 TOBRAMYCIN 000 Not apply 001 001 001 - SUSCEPTIB. 24 24 24 100
2020-245 006 VITEK SYS. 067 TRIME/SULF 000 Not apply 001 001 001 - SUSCEPTIB. 38 38 38 100
2020-245 006 VITEK SYS. 072 CEFEPIME 000 Not apply 001 001 001 - SUSCEPTIB. 31 31 31 100
2020-245 006 VITEK SYS. 073 PIPER/TAZO 000 Not apply 001 001 001 - SUSCEPTIB. 19 19 19 100
2020-245 006 VITEK SYS. 080 LEVOFLOXA. 000 Not apply 001 001 001 - SUSCEPTIB. 19 19 19 100
2020-245 006 VITEK SYS. 096 ERTAPENEM 000 Not apply 001 001 001 - SUSCEPTIB. 22 22 22 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 20 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 21 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 170 PARASITOLOGY GRP: 350 ID OF PARASITES
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
120 IDENT OF PARASITES
2020-311 003 E. coli 002 CYSTS 003 - MODERATE 36 3 0 0
2020-311 003 E. coli 002 CYSTS 002 - FEW 36 33 0 0
2020-311 004 Endo. nana 002 CYSTS 004 - MANY 10 1 0 0
2020-311 004 Endo. nana 002 CYSTS 003 - MODERATE 10 2 0 0
2020-311 004 Endo. nana 002 CYSTS 002 - FEW 10 7 0 0
2020-311 009 Giardia l. 002 CYSTS 002 004 004 - MANY 107 64 106 100
2020-311 009 Giardia l. 002 CYSTS 002 004 006 - PAR NOT RE 107 1 106 0
2020-311 009 Giardia l. 002 CYSTS 002 004 003 - MODERATE 107 37 106 100
2020-311 009 Giardia l. 002 CYSTS 002 004 002 - FEW 107 5 106 100
2020-312 004 Endo. nana 002 CYSTS 002 004 003 - MODERATE 107 3 20 100
2020-312 004 Endo. nana 002 CYSTS 002 004 002 - FEW 107 17 20 100
2020-312 004 Endo. nana 002 CYSTS 002 004 006 - PAR NOT RE 107 87 20 0
2020-312 018 Strongylo. 004 LARVAE 002 004 003 - MODERATE 107 14 103 100
2020-312 018 Strongylo. 004 LARVAE 002 004 002 - FEW 107 85 103 100
2020-312 018 Strongylo. 004 LARVAE 002 004 004 - MANY 107 4 103 100
2020-312 018 Strongylo. 004 LARVAE 002 004 006 - PAR NOT RE 107 4 103 0
2020-313 050 NPF 005 NOT APPLY 005 005 005 - NOT APPLY 107 103 103 100
2020-313 050 NPF 005 NOT APPLY 005 005 006 - PAR NOT RE 107 4 103 0
2020-314 050 NPF 005 NOT APPLY 005 005 005 - NOT APPLY 107 107 107 100
2020-315 050 NPF 005 NOT APPLY 005 005 006 - PAR NOT RE 107 12 95 0
2020-315 050 NPF 005 NOT APPLY 005 005 005 - NOT APPLY 107 95 95 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 22 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 170 PARASITOLOGY GRP: 360 PRES/ABS OF PARASITE
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
121 PRESENCE OR ABSENCE
2020-311 002 002 002 002 001 - Absence 26 1 25 0
2020-311 002 002 002 002 002 - Presence 26 25 25 100
2020-312 002 002 002 002 002 - Presence 25 24 24 100
2020-312 002 002 002 002 001 - Absence 25 1 24 0
2020-313 001 001 001 001 001 - Absence 25 25 25 100
2020-314 001 001 001 001 002 - Presence 25 1 24 0
2020-314 001 001 001 001 001 - Absence 25 24 24 100
2020-315 001 001 001 - Absence 25 16 16 100
2020-315 001 001 002 - Presence 25 9 16 0
SPE: 50 MICROBIOLOGY SUB: 180 Virology GRP: 400 Influenza A & B
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
176 INFLUENZA A&B QUALI
2020-251 001 INFLU. A 001 BINAX NOW 002 002 002 002 002 - POSITIVE 12 12 12 100
2020-251 001 INFLU. A 003 Sofia CLIA 002 002 002 002 002 - POSITIVE 94 94 94 100
2020-251 001 INFLU. A 004 Sekisui Os 002 002 002 002 001 - NEGATIVE 136 1 135 0
2020-251 001 INFLU. A 004 Sekisui Os 002 002 002 002 002 - POSITIVE 136 135 135 100
2020-251 001 INFLU. A 006 Quidel Flu 002 002 002 002 002 - POSITIVE 55 55 55 100
2020-251 001 INFLU. A 007 BD Veritor 002 002 002 002 002 - POSITIVE 22 22 22 100
2020-251 001 INFLU. A 008 Remel x/p 002 002 002 002 002 - POSITIVE 18 18 18 100
2020-251 001 INFLU. A 010 OraSure 002 002 002 002 001 - NEGATIVE 187 2 185 0
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 23 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 180 Virology GRP: 400 Influenza A & B
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-251 001 INFLU. A 010 OraSure 002 002 002 002 002 - POSITIVE 187 185 185 100
2020-251 001 INFLU. A 012 BIOSIG A+B 002 002 002 002 002 - POSITIVE 149 149 149 100
2020-251 001 INFLU. A 013 ImmunoCard 002 002 002 002 002 - POSITIVE 12 12 12 100
2020-251 002 INFLU. B 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-251 002 INFLU. B 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 94 94 94 100
2020-251 002 INFLU. B 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 136 136 136 100
2020-251 002 INFLU. B 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-251 002 INFLU. B 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
2020-251 002 INFLU. B 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-251 002 INFLU. B 010 OraSure 001 001 001 001 001 - NEGATIVE 185 185 185 100
2020-251 002 INFLU. B 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 149 149 149 100
2020-251 002 INFLU. B 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
176 INFLUENZA A&B QUALI
2020-252 001 INFLU. A 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-252 001 INFLU. A 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 94 94 94 100
2020-252 001 INFLU. A 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 136 136 136 100
2020-252 001 INFLU. A 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-252 001 INFLU. A 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
2020-252 001 INFLU. A 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-252 001 INFLU. A 010 OraSure 001 001 001 001 001 - NEGATIVE 185 185 185 100
2020-252 001 INFLU. A 012 BIOSIG A+B 001 001 001 001 002 - POSITIVE 149 1 148 0
2020-252 001 INFLU. A 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 149 148 148 100
2020-252 001 INFLU. A 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-252 002 INFLU. B 001 BINAX NOW 002 002 002 002 002 - POSITIVE 12 12 12 100
2020-252 002 INFLU. B 003 Sofia CLIA 002 002 002 002 002 - POSITIVE 94 94 94 100
2020-252 002 INFLU. B 004 Sekisui Os 002 002 002 002 002 - POSITIVE 136 136 136 100
2020-252 002 INFLU. B 006 Quidel Flu 002 002 002 002 002 - POSITIVE 55 55 55 100
2020-252 002 INFLU. B 007 BD Veritor 002 002 002 002 002 - POSITIVE 22 22 22 100
2020-252 002 INFLU. B 008 Remel x/p 002 002 002 002 002 - POSITIVE 18 18 18 100
2020-252 002 INFLU. B 010 OraSure 002 002 002 002 002 - POSITIVE 187 187 187 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 24 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 180 Virology GRP: 400 Influenza A & B
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-252 002 INFLU. B 012 BIOSIG A+B 002 002 002 002 002 - POSITIVE 149 148 148 100
2020-252 002 INFLU. B 012 BIOSIG A+B 002 002 002 002 001 - NEGATIVE 149 1 148 0
2020-252 002 INFLU. B 013 ImmunoCard 002 002 002 002 002 - POSITIVE 12 12 12 100
176 INFLUENZA A&B QUALI
2020-253 001 INFLU. A 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-253 001 INFLU. A 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 93 93 93 100
2020-253 001 INFLU. A 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 137 137 137 100
2020-253 001 INFLU. A 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-253 001 INFLU. A 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
2020-253 001 INFLU. A 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-253 001 INFLU. A 010 OraSure 001 001 001 001 001 - NEGATIVE 188 188 188 100
2020-253 001 INFLU. A 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 149 149 149 100
2020-253 001 INFLU. A 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-253 002 INFLU. B 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-253 002 INFLU. B 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 95 95 95 100
2020-253 002 INFLU. B 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 135 135 135 100
2020-253 002 INFLU. B 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-253 002 INFLU. B 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
2020-253 002 INFLU. B 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-253 002 INFLU. B 010 OraSure 001 001 001 001 001 - NEGATIVE 186 186 186 100
2020-253 002 INFLU. B 012 BIOSIG A+B 001 001 001 001 002 - POSITIVE 149 1 148 0
2020-253 002 INFLU. B 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 149 148 148 100
2020-253 002 INFLU. B 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-254 001 INFLU. A 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-254 001 INFLU. A 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 94 94 94 100
2020-254 001 INFLU. A 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 136 136 136 100
2020-254 001 INFLU. A 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-254 001 INFLU. A 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 25 (27)DATE : 7/27/2020TIME : 08:48:51
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 180 Virology GRP: 400 Influenza A & B
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-254 001 INFLU. A 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-254 001 INFLU. A 010 OraSure 001 001 001 001 001 - NEGATIVE 187 187 187 100
2020-254 001 INFLU. A 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 149 149 149 100
2020-254 001 INFLU. A 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-254 002 INFLU. B 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-254 002 INFLU. B 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 94 94 94 100
2020-254 002 INFLU. B 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 136 136 136 100
2020-254 002 INFLU. B 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-254 002 INFLU. B 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
2020-254 002 INFLU. B 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-254 002 INFLU. B 010 OraSure 001 001 001 001 001 - NEGATIVE 187 187 187 100
2020-254 002 INFLU. B 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 149 148 148 100
2020-254 002 INFLU. B 012 BIOSIG A+B 001 001 001 001 002 - POSITIVE 149 1 148 0
2020-254 002 INFLU. B 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
176 INFLUENZA A&B QUALI
2020-255 001 INFLU. A 001 BINAX NOW 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-255 001 INFLU. A 003 Sofia CLIA 001 001 001 001 001 - NEGATIVE 94 94 94 100
2020-255 001 INFLU. A 004 Sekisui Os 001 001 001 001 001 - NEGATIVE 136 136 136 100
2020-255 001 INFLU. A 006 Quidel Flu 001 001 001 001 001 - NEGATIVE 55 55 55 100
2020-255 001 INFLU. A 007 BD Veritor 001 001 001 001 001 - NEGATIVE 22 22 22 100
2020-255 001 INFLU. A 008 Remel x/p 001 001 001 001 001 - NEGATIVE 18 18 18 100
2020-255 001 INFLU. A 010 OraSure 001 001 001 001 001 - NEGATIVE 185 185 185 100
2020-255 001 INFLU. A 012 BIOSIG A+B 001 001 001 001 001 - NEGATIVE 150 149 149 100
2020-255 001 INFLU. A 012 BIOSIG A+B 001 001 001 001 002 - POSITIVE 150 1 149 0
2020-255 001 INFLU. A 013 ImmunoCard 001 001 001 001 001 - NEGATIVE 12 12 12 100
2020-255 002 INFLU. B 001 BINAX NOW 002 002 002 002 002 - POSITIVE 13 13 13 100
2020-255 002 INFLU. B 003 Sofia CLIA 002 002 002 002 002 - POSITIVE 94 94 94 100
2020-255 002 INFLU. B 004 Sekisui Os 002 002 002 002 002 - POSITIVE 136 136 136 100
2020-255 002 INFLU. B 006 Quidel Flu 002 002 002 002 002 - POSITIVE 55 55 55 100
2020-255 002 INFLU. B 007 BD Veritor 002 002 002 002 002 - POSITIVE 22 22 22 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 26 (27)DATE : 7/27/2020TIME : 08:48:52
Participant Summary
SPE: 50 MICROBIOLOGY SUB: 180 Virology GRP: 400 Influenza A & B
TEST SAMPLE
LEVEL 1RESULT CODE
LEVEL 2RESULT CODE
LEVEL 3RESULT CODE
PARTLOW/HIGH
REFEREELOW/HIGH
COMMERLOW/HIGH
REPORTEDVALUE
PARTLABS
# LABSANSW
# "SF" LABS Score
2020-255 002 INFLU. B 008 Remel x/p 002 002 002 002 002 - POSITIVE 18 18 18 100
2020-255 002 INFLU. B 010 OraSure 002 002 002 002 002 - POSITIVE 187 187 187 100
2020-255 002 INFLU. B 012 BIOSIG A+B 002 002 002 002 002 - POSITIVE 147 146 146 100
2020-255 002 INFLU. B 012 BIOSIG A+B 002 002 002 002 001 - NEGATIVE 147 1 146 0
2020-255 002 INFLU. B 013 ImmunoCard 002 002 002 002 002 - POSITIVE 12 12 12 100
7/27/2020 PROFICIENCY TESTING SERVICELABORATORY SERVICES PROGRAM
DEPARTMENT OF HEALTH OF PUERTO RICO
MONTH 5 OF YEAR 2020
PAGE : 27 (27)DATE : 7/27/2020TIME : 08:48:52
Participant Summary
